Lukas Flatz
Kantonsspital St. Gallen(CH)University of Tübingen(DE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Cutaneous Melanoma Detection and Management, CAR-T cell therapy research, Nonmelanoma Skin Cancer Studies
Most-Cited Works
- → Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab(2017)995 cited
- → STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity(2015)569 cited
- → Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer(2019)383 cited
- → Interferons Direct Th2 Cell Reprogramming to Generate a Stable GATA-3+T-bet+ Cell Subset with Combined Th2 and Th1 Cell Functions(2010)333 cited
- → Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy(2019)256 cited
- → Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection(2015)179 cited